NunaBio, the synthetic DNA spin out from Newcastle University, has been awarded its first Innovate UK funding for the development of its novel DNA-based technology.
The company, founded on research from the Pike/Tuite Group, will use the funding to expand and develop technology which allows the rapid, scalable, enzymatic synthesis of very long DNA. Primary applications include integration into improved biosensors, synthesis of cell and gene therapies and development of DNA-based reagents and consumables.
CTO Dr Andrew Pike says
“ Our approach enables us to synthesize DNA that contains a greater variety of repeat units beyond those that are currently available. I believe, as we build designer sequences of DNA, that this will create many possibilities for us to explore in the future.”
